# Expanded Access for BLZ-100 (Tozuleristide)

> **NCT04343274** · — · NO_LONGER_AVAILABLE · sponsor: **Blaze Bioscience Inc.**

## Conditions studied

_None listed._

## Interventions

- **DRUG:** Tozuleristide

## Key facts

- **NCT ID:** NCT04343274
- **Lead sponsor:** Blaze Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04343274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04343274, "Expanded Access for BLZ-100 (Tozuleristide)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04343274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*